Related Experiment Videos

The effect of phorbol esters on tumor cell sensitivity to macrophage-mediated cytostasis

L M Nycum1, M Fishman

  • 1Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.

Cellular Immunology
|January 1, 1989
PubMed

Insights

Tumor cells treated with TPA resisted macrophage-mediated cytostasis, with cell cycle phase influencing TPA

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Cycle Regulation

Background:

  • Macrophages play a crucial role in tumor surveillance through cytostatic mechanisms.
  • Tumor cells can develop resistance to immune-mediated inhibition.
  • Phorbol esters, like TPA, are known modulators of cellular processes.

Purpose of the Study:

  • To investigate the effect of TPA on macrophage-mediated cytostasis of EL4 thymoma cells.
  • To determine if cell cycle phase influences TPA-induced resistance to macrophage-mediated cytostasis.

Main Methods:

  • Utilized a mouse syngeneic system with EL4 thymoma cells and C57B1/6 mouse macrophages.
  • Assessed macrophage-mediated cytostasis on non-elutriated and elutriated tumor cells.
  • Treated tumor cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) and evaluated changes in susceptibility.

Main Results:

  • EL4 thymoma cells were sensitive to macrophage-mediated cytostasis.
  • TPA pretreatment rendered tumor cells resistant to macrophage-mediated cytostasis.
  • TPA-induced resistance was cell cycle-dependent: G1/early S phase cells became resistant, while late S phase cells remained sensitive.

Conclusions:

  • TPA confers resistance to macrophage-mediated cytostasis in a cell cycle-dependent manner.
  • The effect of TPA on tumor cell susceptibility is reversible.
  • Non-tumor-promoting phorbol ester alpha-PDD did not induce similar resistance, suggesting a specific mechanism for TPA.

Related Concept Videos